Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients

NCT02040415 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Back Pain

Interventions

DRUG: DW-1030(eperisone HCl) 75mg
DRUG: Myonal Tab.(eperisone HCl) 50mg
DRUG: Placebo drug of DW-1030
DRUG: Placebo drug of Myonal Tab.

Sponsor

Daewon Pharmaceutical Co., Ltd.